Feature | March 01, 2021| By Dave Fornell, Editor

Most Popular Cardiology Technology Content in February 2021 

The two biggest cardiac device technology stories in February included the Boston Scientific recall of its S-ICD system, and the FDA clearance of the Shockwave intravascular lithotripsy system to break up calcified lesions in the coronary arteries.

The two biggest cardiac device technology stories in February included the Boston Scientific recall of its S-ICD system, and the FDA clearance of the Shockwave intravascular lithotripsy system to break up calcified lesions in the coronary arteries.

March 1, 2021 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) magazine website from the month of February 2021. This is based on the website’s 676,038 pageviews for the month.

1. The Long-term Cardiovascular Impact of COVID-19

2. Addressing Atrial Fibrillation in the World of COVID-19

3. Boston Scientific Recalls Emblem S-ICD After 26 Serious Injuries and One Death

4. FDA Clears Coronary Intravascular Lithotripsy to Breakup Calcified Lesions With Sound Waves

5. New ECG System Eliminated Wire Leads to Simlify Standard 12-Lead ECG

6. Cardiology Product Comparison Charts Aid in Buying Decisions

7. ACC Plans for In-Person 2021 Meeting in May With Wearable Biomonitors

8. Image Gallery Showing Impact of the COVID-19 Pandemic

9. Bicuspid Aortic TAVR May Create Huge Market For Transcatheter Valves

10. VIDEO: Intravascular Lithotripsy to Treat Severely Calcified Coronary Artery Lesions — Interview with Dean Kereiakes, M.D.

11. FDA OKs Use New Version of Carmat Artificial Heart in U.S. Early Feasibility Study

12. First Disposable Cath Lab Robot Technology Acquired by Ascendum

13. Modern Vascular Opens New Outpatient Cath Lab to Treat Peripheral Artery Disease

14. CGuard Carotid Embolic Protection Device Trial Will be Led by Chris Metzger

15. FDA Clears Medtronic DiamondTemp Ablation System to Treat Atrial Fibrillation

 

Related Popular Cardiology Technology Content: 

Most Popular Cardiology Technology Content in January 2021 

Most Popular Cardiology Technology Content in December 2020

Top 25 Stories in Cardiology in 2020

Top 25 Cardiology Videos on DAIC in 2020

Most Popular Cardiology Technology Content in November 2020

Related Content

Ablation and Biventricular Pacing Boosts Survival in Selected Atrial Fibrillation Patients in APAF-CRT Trial. #ESC #ESCcongress
News | Atrial Fibrillation | September 13, 2021
September 13, 2021 — Ablation plus cardiac resynchronization therapy (CRT) is superior to pharmacological rate contro
The Medtronic Linq II implantable cardiac monitor.

The Medtronic Linq II implantable cardiac monitor.

News | Atrial Fibrillation | September 08, 2021
September 8, 2021 — Continuous heart rhythm monitoring – with...
The Adagio Medical iCLAS cryoablation system is commercial in Europe and is also part of an ongoing FDA IDE trial in the U.S. #HRS21
News | Atrial Fibrillation | August 09, 2021
August 9, 2021 — Adagio Medical Inc., a provider of catheter ablation technologies for...
Rhythm Therapeutics gene, stem cell, therapy for atrial fibrillation.
News | Atrial Fibrillation | April 19, 2021
April 19, 2021 — National Heart, Lung, and Blood Institute (NHLBI) has awarded a grant for $462,689 to Rhythm Therape
Medtronic's DiamondTemp Ablation (DTA) system is FDA cleared to treat patients with recurrent, symptomatic paroxysmal atrial fibrillation (AF) and who have been unresponsive to drug therapy. The DiamondTemp system is the first FDA-approved, temperature-controlled, irrigated radiofrequency (RF) ablation system with diamonds currently available to deliver ablations.

Medtronic's DiamondTemp Ablation (DTA) system is FDA cleared to treat patients with recurrent, symptomatic paroxysmal atrial fibrillation (AF) and who have been unresponsive to drug therapy. The DiamondTemp system is the first FDA-approved, temperature-controlled, irrigated radiofrequency (RF) ablation system with diamonds currently available to deliver ablations.

News | Atrial Fibrillation | January 29, 2021
January 29, 2021 — The U.S.
Patients with atrial fibrillation are at far greater risk of a catastrophic COVID outcomes, so steps should be taken to reduce AFib risks in addition to precautions against COVID like making, hand washing and social distancing. Images include an electromap from an AF ablation procedure and a COVID-19 from the CDC. 

Patients with atrial fibrillation are at far greater risk of a catastrophic COVID outcomes, so steps should be taken to reduce AFib risks in addition to precautions against COVID like making, hand washing and social distancing. Images include an electromap from an AF ablation procedure and a COVID-19 from the CDC. 

Feature | Atrial Fibrillation | January 27, 2021 | By John D. Day, M.D., T. Jared Bunch, M.D., and Matthew D. LaPlante
In our most challenging and distressing days, it is nice to think about a post-COVID-19 world. 
ECG with paroxysm correct form of atrial flutter. Getty Images

ECG with paroxysm correct form of atrial flutter. Getty Images

News | Atrial Fibrillation | December 23, 2020
December 23, 2020 — The American College of Cardiology (ACC) and the American Heart Association (AHA) has made two up